Jennifer Lynn Minai-Azary
CIK 1844398 · Chief Financial Officer · last filed 2026-02-23
Jennifer Lynn Minai-Azary is a Chief Financial Officer who has filed 10 SEC Form 4 insider transactions across 2 companies since 2021. The most recent filing, for CNTX, was dated Feb 23, 2026. Across all open-market trades the lifetime net is +$71.0K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $111.2K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$111.2K
2
10
$71.0K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CNTX | Chief Financial Officer | 80,010 | $1.39 | $111.2K | $71.0K | 9 | 2026-02-23 |
| Tempest Therapeutics, Inc. (MLND) Delisted | Chief Financial Officer | — | $15.90 | — | $0 | 1 | 2021-03-02 |
Recent Filings
10 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-02-23 | CNTX | Grant (A) | — | $0 | EDGAR |
| 2025-06-10 | CNTX | Buy (P) | +40,010 | $25.5K | EDGAR |
| 2025-02-14 | CNTX | Grant (A) | — | $0 | EDGAR |
| 2024-03-22 | CNTX | Grant (A) | — | $0 | EDGAR |
| 2023-02-14 | CNTX | Grant (A) | — | $0 | EDGAR |
| 2022-12-19 | CNTX | Buy (P) | +25,000 | $18.5K | EDGAR |
| 2022-08-17 | CNTX | Buy (P) | +15,000 | $27.0K | EDGAR |
| 2022-02-25 | CNTX | Grant (A) | — | $0 | EDGAR |
| 2021-11-01 | CNTX | Grant (A) | — | $0 | EDGAR |
| 2021-03-02 | Tempest Therapeutics, Inc. (MLND) Delisted | Grant (A) | — | $0 | EDGAR |